Ideas & Insights

Patient support programs can become a risk to life sciences product manufacturers if used to gain preferential treatment for their products.

Wearable tech’s transformative power promotes healthy lifestyles, lowers insurance coverage spending and increases employee engagement.

Life sciences organizations are collecting customer data at an enormous rate leaving them vulnerable to cyberattacks.

Tax highlights for life sciences companies as you prepare for year-end filing and a look ahead to prepare for 2019.

Healthcare-focused private equity, lending and finance conference will explore ways to successfully close transactions and achieve growth.

Rhythm Pharmaceuticals discusses how RSM helped make a success with their recent implementation of a new ERP system.

VP & Corporate Controller, John Hulburt, discusses Rhythm's recent implementation of the Microsoft Dynamics 365 ERP.

With the recent attention around speakers programs, ensure your life science organization has the proper controls in place to reduce risk.

Examine PE deals, M&A trends and the economic implications of both in the newly released 2018 Annual HC & LS Industry Spotlight.

Check out the recording below to learn how to position a security program to respond to cybersecurity threats in the life sciences industry.

RSM's industry insider shares insights on top trends and issues affecting middle market life sciences businesses.

Bioscience insiders share why balancing science, as well as finance and accounting, is essential for growing biotechs.

Learn the key risk areas for life sciences organizations to consider as they implement controls that promote compliance and deter fraud.

See why RSM has a long record of on-time, on-budget deployments for clinical-stage companies due to our unique deployment model.

RSM helped Tanner Pharma overcome challenges with its NetSuite implementation provider, setting a foundation for growth and ongoing support.

Life sciences companies must address the growing trove of data as they seek to bring personalized therapies, drugs and devices to market.

Enhanced tax deduction may be available for drug inventory contributions made to certain charitable organizations.

Pharmaceutical, biotech and medical device company finance leaders discuss ASC 842 lease accounting adoption complexities and challenges.

In challenging sellers’ market for life sciences and medical devices, private equity firms and strategics vie competitively.

What were the important takeaway topics from CBI’s Finance & Accounting for Biosciences Conference? Read our recap.